Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) CFO Kory James Wentworth sold 950 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $13.48, for a total transaction of $12,806.00. Following the completion of the transaction, the chief financial officer now directly owns […]
BOSTON, Aug. 29, 2023 Entrada Therapeutics, Inc. , a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle -therapeutics as a.
CHI Advisors LLC Takes Position in Entrada Therapeutics, Inc (NASDAQ:TRDA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) fell 6% on Monday . The company traded as low as $15.40 and last traded at $15.42. 19,255 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 73,412 shares. The stock had previously closed at $16.41. Wall Street Analyst Weigh […]
Research Analysts Issue Forecasts for Entrada Therapeutics, Inc s Q3 2023 Earnings (NASDAQ:TRDA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.